# Dexamethasone for PENG Block in Total Hip Arthroplasty

> **NCT06470139** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Hip Osteoarthritis
- Hip Arthropathy
- Hip Pain Chronic

## Interventions

- **DRUG:** Ropivacaine 0.2% Injectable Solution
- **DRUG:** Ropivacaine 0.2% Injectable Solution + 4mg Dexamethasone

## Key facts

- **NCT ID:** NCT06470139
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-13
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-02-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06470139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06470139, "Dexamethasone for PENG Block in Total Hip Arthroplasty". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT06470139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*